drug · antibody
lorigerlimab
Phase 2updated 3mo agoby $MGNX MACROGENICS INC🔗 ChEMBL
Phase 2community read0 votes
Antibody drug with a maximum clinical stage of Phase 2 (across all indications), with 3 investigational indications.
indications
indications
Colorectal CancerMelanoma
all catalysts(0)
nothing on the calendar yet
Trials studying lorigerlimab
- phase2Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)
- phase2A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer
- phase2A Study of Lorigerlimab in Participants With Advanced Solid Tumors
- phase2A Trial of Regorafenib Plus Lorigerlimab in Patients With Locally Recurrent or Regrowing pMMR/MSS Localized Rectal Cancer
- phase2Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]
- phase1A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors
- phase1MGD019 DART® Protein in Unresectable/Metastatic Cancer
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 48m ago
Found something off?
comments(0)
5-min edit window · permanent after that